17β-Hydroxyandrost-4...
Vérifier sur isomerdesign
Testosterone
Vérifier sur pubchem
Testosterone
Vérifier sur drugmap
Data
InChI: InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3
Synonymes: EC 200-370-5,Synandrol F, COL 1621, AA 2500,Sustanone, Oreton,17b-hydroxy-(9b)-androst-4-en-3-one,CPD000058344,EINECS 200-370-5,Testandrone, Testopropon,Percutacrine androgenique,17a-hydroxy-14b-androst-4-en-3-one,delta(sup 4)-Androsten-17(beta)-ol-3-one,(17beta)-17-Hydroxyandrost-4-en-3-one,Halotensin,Homosterone,TESTOSTERONE [INN], Andronate 200, Halotensin,Testopropon,Neotestis,Androgel 1.62%,Testosterone solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material,4-Androsten-3-one-17b-ol,17b-hydroxy-(10a)-androst-4-en-3-one,Nasobol,4-androstene-17beta-ol-3-one,MLS002174283, 7-beta-Hydroxyandrost-4-en-3-one,17b-Testosterone,Testosterone, 1,Testosteronum [INN-Latin],Androst-4-en-3-one, 17-beta-hydroxy-,HMS2272P03,Testryl,MLS001424262, Virosterone,17b-Hydroxy-androst-4-en-3-on,Malogen, aquaspension injection,(+-)-8-iso-testosterone, Sustanone,Testobase,NSC-9700, 17-Hydroxy-(17beta)-androst-4-en-3-one,Testosterone and its esters, (17beta)-17-Hydroxyandrost-4-en-3-one,Andrusol, 17-Hydroxy-4-androsten-3-one, 17-Hydroxy-(17-beta)-androst-4-en-3-one,Tox21_200689,17b-hydroxy-4-androsten-3-one, Andropository 200,TESTOSTERONE [MI],HY-15554A,17b-Hydroxyandrost-4-ene-3-one,Primotest, Malerone, Testoderm,9b,10a-testosterone,17-.beta.-Hydroxyandrost-4-en-3-one,17.beta.-Hydroxy-.DELTA.4-androsten-3-one,Androst-4-en-3-one, 17-hydroxy-, (17b)-,Lumitestosteron,Malerone,RB3046,component of Di-Genik (Salt/Mix),(17b)-17-hydroxy-androst-4-en-3-one,Axiron (TN),17?-hydroxyandrost-4-en-3-one; epitestosterone; 17-epi-Testosterone; 17?-cis-Testosterone; 4-Androstene-17?-ol-3-one; Isotestosterone, Testosterone [Androgenic steroids, anabolic],9b-testosterone, Testred Cypionate 200,TESTOSTERONE [EP IMPURITY],Sustanon,TESTOSTERONE [INCI], Depotest, Homosterone,Virormone,Testosterone 1.0 mg/ml in Acetonitrile,17-Hydroxy-(17beta)-androst-4-en-3-one,Androderm,13-iso-testosterone,Fortesta,17a-hydroxy-androst-4-en-3-one,testosterone,CMC_13449,1i37,MLS000563091,CDB 111C,17beta-Hydroxyandrost-4-ene-3-one, 17beta-Hydroxy-delta(sup4)-androsten-3-one, Testrin-P.A,trans-Testosterone, CDB 111C,Testopel Pellets, Striant (TN),Intrinsa,rac-17b-hydroxy-(8a)-androst-4-en-3-one,Q-101251,Natesto,Testoject-50,Testosterone [USP:INN:BAN],Teslen,TESTOSTERONE [ORANGE BOOK],Tefina, Andro 100, Striant, Sustanon, Androgel (TN),Geno-cristaux gremy,Homosteron,CP 601B,Orquisteron,GTPL2858,TESTOSTERONE ENANTATE IMPURITY D [EP IMPURITY],Androderm (TN),NCGC00258243-01,17β-Hydroxyandrost-4-en-3-one,BIDD:ER0555,SMR001261453,mpp10, Testosteroid, Testosterone hydrate,(8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one,component of Mal-O-Fem (Salt/Mix),Androst-4-ene-17b-ol-3-one,DTXSID8022371,Testro AQ,17-beta-Hydroxyandrost-4-en-3-one, Testandrone, Andronate 100,CCRIS 574,CAS-58-22-0,Testogel,SMR000058344,AB00973630-03, 17beta-Hydroxy-4-androsten-3-one,LMST02020002,CompleoTRT,AndroGel,Axiron,17b-hydroxy-(9b,10a)-androst-4-en-3-one,LPCN 1021,Oreton-F,Vogelxo,beta testosterone,DB00624,rac-17b-hydroxy-(13a)androst-4-en-3-one,17-hydroxy-androst-4-en-3-one, Testosterona [INN-Spanish],Sustason 250,Tostrex, Testoderm Tts, 17-beta-Hydroxy-delta(sup 4)-androsten-3-one, Testro AQ,Androst-4-en-3-one, 17-hydroxy-, (17-beta)-,Testim,TESTOSTERONE [JAN], Androderm (TN),AC-14899,(17?)-17-Hydroxyandrost-4-en-3-one, Testim,Testosteron, Testoviron Schering,component of Tostrex (Salt/Mix),17beta-hydroxy-4-androsten-3one,003T654,SCHEMBL8452,Androst-4-en-17b-ol-3-one,Testosterone for impurity D identification, European Pharmacopoeia (EP) Reference Standard,rac-17b-hydroxy-androst-4-en-3-one,Testosterone ciii,Andronaq, Primotest,NSC 9700, Testosterone (JAN/USP),CS-1415,CHEMBL386630,TESTOSTERONE [EP MONOGRAPH], Intrinsa,Striant (TN),Androst-4-en-3-one, 17-hydroxy, (17.beta.)-,UNII-3XMK78S47O, Geno-cristaux gremy,17b-hydroxy-(8a)-androst-4-en-3-one,Testoviron T,4-Androsten-17beta-ol-3-one,Testoderm,Androlin,component of Duogen (Salt/Mix),17-hydroxy-D4-androsten-3-one,AKOS015894897, Virilon IM,4-Androsten-3-one-17.beta.-ol,Testosterone 100 microg/mL in Acetonitrile,Andropatch,HMS2272B03,7-beta-Hydroxyandrost-4-en-3-one,17b-hydroxy-8a-androst-4-en-3-one,58-22-0, Malogen in Oil,COL 1621, Testosterona,D00075,17.beta.-Testosterone,DSSTox_GSID_22371,(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one, Testrone, (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one, Perandren,S00309,Andro 100,Striant, Delta(sup 4)-Androsten-17(beta)-ol-3-one,component of Di-Met (Salt/Mix), Virormone,Androst-4-en-3-one, 17-hydroxy-, (17beta)-,Testosterone (JAN/USP),Perandren, Testoviron T, Delta4-Androsten-17beta-ol-3-one,Tostrelle,(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one, Oreton F,Testex,Testrone, Orquisteron, Testaqua,Virosterone,17b-hydroxy-(8a,10a)-androst-4-en-3-one,Androst-4-en-3-one, 17beta-hydroxy-,TESTOSTERONE [VANDF],MLS001306401, Androsorb, Trans-Testosterone,17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one, 17beta-Hydroxy-3-oxo-4-androstene,Testostosterone,Androst-4-en-3-on-17B-ol, Testiculosterone, Andryl 200,ANDROID-T,Testosteronum,17-Hydroxyandrost-4-en-3-one, (17.beta.)-,TESTOSTERONE PROPIONATE IMPURITY C [EP IMPURITY],Testosterone for system suitability, European Pharmacopoeia (EP) Reference Standard, Neotestis,Viatrel,Testoviron Schering, Neo-Hombreol F,TESTOSTERONE [USP MONOGRAPH],(8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, Testoviron, Mertestate,NCGC00091018-01,Testosterona [INN-Spanish],CHEBI:17347,HMS2052N11,DSSTox_RID_76563,Testosterona,(+)-testosterone,17b-hydroxy-(13a)-androst-4-en-3-one,delta4-Androsten-17beta-ol-3-one,Testosterone, VETRANAL(TM), analytical standard, Testolin,(17β)-17-Hydroxyandrost-4-en-3-one, Synandrol F, CMC_13449,Androgel 1%, Androderm,NC00439,Testolin, Andrusol, Teslen, Testosteronum,BDBM8885,Testosterone, purum, >=99.0% (HPLC),17b-Hydroxy-D4-androsten-3-one, Testogel,Testosteroid, Primoteston,Testosterone, European Pharmacopoeia (EP) Reference Standard, Testamone 100, Testopel Pellets,Cristerone T,rac-17b-hydroxy-(9b,10a)androst-4-en-3-one,Primoteston,TESTOSTERONE [GREEN BOOK],TESTOSTERONE [MART.],4-Androsten-3-one, 17b-hydroxy-,Epitestosteron,Neo-Hombreol F,TESTOSTERONE [EMA EPAR],17-beta-Hydroxy-delta(sup 4)-androsten-3-one,Testosterone; 4-Androsten-17?-ol-3-one; 17?-Hydroxy-4-androsten-3-one,Testiculosterone, Testosteronum [INN-Latin],Cristerona T,CCG-101189,C00535,17beta-Hydroxy-4-androsten-3-one,4-Androsten-17.beta.-ol-3-one,Epitope ID:135865,ZINC118912393, Beta testosterone, Neo-testis, Testobase, Testostosterone,8-iso-testosterone,Testosterone EP Impurity C, Testim (TN),Testosterone, cell culture tested,17beta-Hydroxy-delta(sup4)-androsten-3-one, 17-beta-Hydroxyandrost-4-en-3-one,Testosterone hydrate,Testoderm Tts,Livensa, Malestrone (amps),DSSTox_CID_2371, Testosterone and its esters, Oreton-F,Androgel (TN), Scheinpharm Testone-Cyp, CP 601B, 4-androstene-17beta-ol-3-one, Percutacrine androgenique,AA 2500, Malogen, aquaspension injection, 17beta-Hydroxyandrost-4-en-3-one,17beta-Hydroxyandrost-4-en-3-one,Testoviron, Homosteron, Andropatch, Relibra, 17beta-Hydroxyandrost-4-ene-3-one,Relibra,Testosterone [Androgenic steroids, anabolic], Cristerona T,Mertestate,Oreton,17b-hydroxy-13a-androst-4-en-3-one,component of Intrinsa (Salt/Mix),Testosterone, >=98%, LibiGel, Sustason 250,17a-hydroxy-13a-androst-4-en-3-one,(+-)-testosterone,D4-Androsten-17b-ol-3-one,ANDROLAN, Cristerone T, T-Cypionate,T0027,17-Hydroxy-(17-beta)-androst-4-en-3-one,Neo-testis,BIM-0061761.0001,TESTOSTERONE [WHO-DD], Testoject-50, 4-Androsten-17beta-ol-3-one,Testosterone solution, 1.0 mg/mL in 1,2-dimethoxyethane, drug standard,HSDB 3398,Q1318776,LibiGel,(+-)-retrotestosterone, Testosteron, Testryl,3XMK78S47O,Bio-T-Gel, Androst-4-en-17beta-ol-3-one,Androst-4-en-3-one, 17-hydroxy-, (17.beta.)-,Malestrone (amps),Testim (TN),17b-hydroxy-androst-4-en-3-one,1050678-68-6, Testosterone [INN:BAN],17a-hydroxy-(13a)-androst-4-en-3-one, 17b-hydroxy-4-androsten-3-one,Androst-4-en-17beta-ol-3-one,MLS001032098,B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E,delta4-androsten-17b-ol-3-one, Delta4-androsten-17b-ol-3-one,(8alpha,10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one, Testosterone solution,TESTOSTERONE [HSDB], Andronaq, 4-Androsten-17-ol-3-one,3kdm, Everone 200, Androlin
Estimated data
Solubility: -4.156 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: No (prediction using frontiersin.org)
Addictivity Prediction: 73.5% (prediction based on www.mdpi.com)
